Abstract 775: Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients
Philip J. Lupo(Emory Healthcare), Aubrey K. Hubbard(National Cancer Institute), Lindsay M. Morton(National Cancer Institute), Jay S. Wunder(Sinai Health System), Sharon A. Savage(National Cancer Institute), Michael E. Scheurer(Emory University), Fernando Lecanda(Chartered Institute of Management Accountants), Maryam Rafati(National Cancer Institute), Katia Scotlandi(Istituto Ortopedico Rizzoli), Bailey A. Martin‐Giacalone(Washington University in St. Louis), Joshua D. Schiffman(Primary Children's Hospital), Wen Luo(National Institutes of Health), Sharon E. Plon(Baylor College of Medicine), Olivier Delattre(Institut Curie), Massimo Serra(Istituto Ortopedico Rizzoli), Fernanda Amary(Royal National Orthopaedic Hospital), Smita Bhatia(University of Alabama at Birmingham), Shengchao Alfred Li(Leidos (United States)), Adrienne M. Flanagan(Royal National Orthopaedic Hospital), Irene L. Andrulis(University of Toronto), Adriana Lori(Emory University), Logan G. Spector(University of Minnesota Medical Center), Katherine A. Janeway(Harvard University), David M. Thomas(New South Wales Department of Health), Rajkumar Venkatramani(Baylor College of Medicine), Michael Dean(National Cancer Institute), W. Ryan Diver(American Cancer Society), Douglas R. Stewart(Cancer Genetics (United States)), Gregory T. Armstrong(St. Jude Children's Research Hospital), Belynda Hicks(Frederick National Laboratory for Cancer Research), Alexander Renwick(Baylor College of Medicine), Mitchell J. Machiela(National Cancer Institute), Bin Zhu(National Cancer Institute), Mandy L. Ballinger(Garvan Institute of Medical Research), Aniko Sabo(Baylor College of Medicine), Douglas S. Hawkins(Seattle Children's Hospital), Laura E. Egolf(National Cancer Institute), Claudia Maria Hattinger(Istituto Ortopedico Rizzoli), Melissa M. Hudson(Cincinnati Children's Hospital Medical Center), Stephen J. Chanock(National Cancer Institute), Jia Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Kevin Wang(Kavli Energy NanoScience Institute), D. Matthew Gianferante(National Cancer Institute), Wen‐Yi Huang(National Institutes of Health), Meredith Yeager(Frederick National Laboratory for Cancer Research), Ana Patiño‐García(Navarre Institute of Health Research), Maria Teresa Landi(National Cancer Institute)
Cited by 0
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Somatic mutations affect key pathways in lung adenocarcinoma
|Nature|2008|2.8k